Triple therapy with oral anticoagulation plus aspirin and clopidogrel is the most often used initial therapy. Risks of restenosis and stent thrombosis do not appear to be abnormally high.

Triple therapy with oral anticoagulation plus aspirin and clopidogrel is the most often used initial therapy. Risks of restenosis and stent thrombosis do not appear to be abnormally high.

AstraZeneca’s triple therapy for chronic obstructive pulmonary disease (COPD), Breztri Aerosphere (budesonide+glycopyrrolate+formoterol fumarate), has been approved in the US following a ...

GlaxoSmithKline is set to launch its COPD triple therapy in the US - and must now show that it can maximise sales of the drug with blockbuster potential. Approved yesterday by the FDA, Trelegy ...

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy. Researchers at Baylor College of Medicine showed ...